全文获取类型
收费全文 | 8173篇 |
免费 | 768篇 |
国内免费 | 265篇 |
专业分类
耳鼻咽喉 | 10篇 |
儿科学 | 88篇 |
妇产科学 | 34篇 |
基础医学 | 365篇 |
口腔科学 | 47篇 |
临床医学 | 1066篇 |
内科学 | 2718篇 |
皮肤病学 | 32篇 |
神经病学 | 250篇 |
特种医学 | 563篇 |
外科学 | 591篇 |
综合类 | 927篇 |
现状与发展 | 1篇 |
预防医学 | 392篇 |
眼科学 | 65篇 |
药学 | 855篇 |
18篇 | |
中国医学 | 868篇 |
肿瘤学 | 316篇 |
出版年
2024年 | 22篇 |
2023年 | 271篇 |
2022年 | 406篇 |
2021年 | 646篇 |
2020年 | 520篇 |
2019年 | 572篇 |
2018年 | 527篇 |
2017年 | 306篇 |
2016年 | 262篇 |
2015年 | 261篇 |
2014年 | 583篇 |
2013年 | 511篇 |
2012年 | 439篇 |
2011年 | 460篇 |
2010年 | 326篇 |
2009年 | 293篇 |
2008年 | 349篇 |
2007年 | 351篇 |
2006年 | 256篇 |
2005年 | 226篇 |
2004年 | 155篇 |
2003年 | 173篇 |
2002年 | 107篇 |
2001年 | 104篇 |
2000年 | 89篇 |
1999年 | 96篇 |
1998年 | 81篇 |
1997年 | 80篇 |
1996年 | 49篇 |
1995年 | 68篇 |
1994年 | 58篇 |
1993年 | 39篇 |
1992年 | 54篇 |
1991年 | 52篇 |
1990年 | 48篇 |
1989年 | 43篇 |
1988年 | 36篇 |
1987年 | 38篇 |
1986年 | 36篇 |
1985年 | 36篇 |
1984年 | 38篇 |
1983年 | 29篇 |
1982年 | 26篇 |
1981年 | 22篇 |
1980年 | 12篇 |
1979年 | 14篇 |
1977年 | 7篇 |
1976年 | 10篇 |
1975年 | 6篇 |
1971年 | 3篇 |
排序方式: 共有9206条查询结果,搜索用时 203 毫秒
991.
Simone Romano Robert M. Judd Raymond J. Kim Han W. Kim Igor Klem John F. Heitner Dipan J. Shah Jennifer Jue Brent E. White Raksha Indorkar Chetan Shenoy Afshin Farzaneh-Far 《JACC: Cardiovascular Imaging》2018,11(10):1419-1429
Objectives
The aim of this study was to evaluate the prognostic value of cardiac magnetic resonance (CMR) feature-tracking–derived global longitudinal strain (GLS) in a large multicenter population of patients with ischemic and nonischemic dilated cardiomyopathy.Background
Direct assessment of myocardial fiber deformation with GLS using echocardiography or CMR feature tracking has shown promise in providing prognostic information incremental to ejection fraction (EF) in single-center studies. Given the growing use of CMR for assessing persons with left ventricular (LV) dysfunction, we hypothesized that feature-tracking–derived GLS may provide independent prognostic information in a multicenter population of patients with ischemic and nonischemic dilated cardiomyopathy.Methods
Consecutive patients at 4 U.S. medical centers undergoing CMR with EF <50% and ischemic or nonischemic dilated cardiomyopathy were included in this study. Feature-tracking GLS was calculated from 3 long-axis cine-views. The primary endpoint was all-cause death. Cox proportional hazards regression modeling was used to examine the association between GLS and death. Incremental prognostic value of GLS was assessed in nested models.Results
Of the 1,012 patients in this study, 133 died during median follow-up of 4.4 years. By Kaplan-Meier analysis, the risk of death increased significantly with worsening GLS tertiles (log-rank p < 0.0001). Each 1% worsening in GLS was associated with an 89.1% increased risk of death after adjustment for clinical and imaging risk factors including EF and late gadolinium enhancement (LGE) (hazard ratio [HR]:1.891 per %; p < 0.001). Addition of GLS in this model resulted in significant improvement in the C-statistic (0.628 to 0.867; p < 0.0001). Continuous net reclassification improvement (NRI) was 1.148 (95% confidence interval: 0.996 to 1.318). GLS was independently associated with death after adjustment for clinical and imaging risk factors (including EF and late gadolinium enhancement) in both ischemic (HR: 1.942 per %; p < 0.001) and nonischemic dilated cardiomyopathy subgroups (HR: 2.101 per %; p < 0.001).Conclusions
CMR feature-tracking–derived GLS is a powerful independent predictor of mortality in a multicenter population of patients with ischemic or nonischemic dilated cardiomyopathy, incremental to common clinical and CMR risk factors including EF and LGE. 相似文献992.
Tetsuya Watanabe Koichi Inoue Kazunori Kashiwase Takanao Mine Keiji Hirooka Ryu Shutta Hiroya Mizuno Yuji Okuyama Yasushi Sakata Shinsuke Nanto 《Journal of electrocardiology》2018,51(6):1111-1115
Background
Atrial fibrillation (AF) and ventricular arrhythmias (VAs) are associated with increased morbidity and mortality. However, data are lacking concerning the association of AF and VAs. This study aimed to clarify the association between AF and VAs and to investigate the effect of amiodarone on the incidence of VAs in patients with implantable cardioverter defibrillators (ICDs).Methods and results
We enrolled 612 patients who had ICDs or who underwent cardiac resynchronization therapy with a defibrillator (CRT-D) and classified them into two groups (sinus rhythm [SR] group, n?=?427; AF group, n?=?185) according to their basal rhythm at enrollment. Patients with paroxysmal AF were grouped into the AF group. The incidence of VAs, i.e., ventricular tachycardia (VT) and ventricular fibrillation (VF), was significantly lower in the AF group than in the SR group (0.54 vs 0.95 episodes/person/year, P?=?0.032). Furthermore, amiodarone use was significantly higher in the AF group than in the SR group (P?=?0.003). Non-use of amiodarone was associated with a significant increase in the occurrence of VT/VF in the two groups. This beneficial suppressive effect of amiodarone on the incidence of VT/VF was present in the AF group regardless of left ventricular ejection fraction (LVEF). However, this effect of amiodarone was present only in patients with LVEF?≥?40% in the SR group.Conclusions
Amiodarone was negatively associated with VT/VF occurrence and was frequently used in ICD/CRT-D patients with AF. VT/VF was controlled by amiodarone in all cases in the AF group but only in patients with an LVEF?≥?40% in the SR group. 相似文献993.
Jimmy Axelsson Björn Wieslander Robert Jablonowski Igor Klem Robin Nijveldt Erik B. Schelbert Peder Sörensson Andreas Sigfridsson Uzma Chaudhry Pyotr G. Platonov Rasmus Borgquist Henrik Engblom David G. Strauss Håkan Arheden Brett D. Atwater Martin Ugander 《Journal of electrocardiology》2018,51(6):1071-1076
Introduction
The relationship between left ventricular (LV) ejection fraction (EF) and LV myocardial scar can identify potentially reversible causes of LV dysfunction. Left bundle branch block (LBBB) alters the electrical and mechanical activation of the LV. We hypothesized that the relationship between LVEF and scar extent is different in LBBB compared to controls.Methods
We compared the relationship between LVEF and scar burden between patients with LBBB and scar (n?=?83), and patients with chronic ischemic heart disease and scar but no electrocardiographic conduction abnormality (controls, n?=?90), who had undergone cardiovascular magnetic resonance (CMR) imaging at one of three centers. LVEF (%) was measured in CMR cine images. Scar burden was quantified by CMR late gadolinium enhancement (LGE) and expressed as % of LV mass (%LVM). Maximum possible LVEF (LVEFmax) was defined as the function describing the hypotenuse in the LVEF versus myocardial scar extent scatter plot. Dysfunction index was defined as LVEFmax derived from the control cohort minus the measured LVEF.Results
Compared to controls with scar, LBBB with scar had a lower LVEF (median [interquartile range] 27 [19–38] vs 36 [25–50] %, p?<?0.001), smaller scar (4 [1–9] vs 11 [6–20] %LVM, p?<?0.001), and greater dysfunction index (39 [30–52] vs 21 [12–35] % points, p?<?0.001).Conclusions
Among LBBB patients referred for CMR, LVEF is disproportionately reduced in relation to the amount of scar. Dyssynchrony in LBBB may thus impair compensation for loss of contractile myocardium. 相似文献994.
The influence of human C-peptide on renal function and glucose utilization in Type 1 (insulin-dependent) diabetic patients 总被引:5,自引:0,他引:5
Summary The possible influence of C-peptide administration on renal function and whole body glucose utilization was examined in 11 patients (Group 1) with Type 1 (insulin-dependent) diabetes mellitus. They were given an i. v. insulin infusion during the night before the study and were euglycaemic at the time of examination. The glomerular filtration rate and effective renal plasma flow were measured by clearance techniques using constant-rate infusions of inulin and sodium para-aminohippurate. After baseline measurements C-peptide was infused during two periods of 60 min at rates of 5 and 30 pmol·kg–1·min–1. In a control study 0.9% NaCl was infused during two 60 min periods in ten Type 1 diabetic patients (Group 2), Glomerular filtration rate decreased by 7%(p<0.001), effective renal plasma flow increased by 3%, (p<0.05) and whole-body glucose utilization rose by approximately 25%(p<0.05) above basal during low-dose C-peptide infusion. Group 2 showed an unaltered glomerular filtration rate, effective renal plasma flow and glucose utilization during 60 min of NaCl infusion. The differences between Group 1 and Group 2 in glomerular filtration rate and glucose utilization were statistically significant. It is concluded that short-term administration of C-peptide in physiological amounts to patients with Type 1 diabetes may reduce the glomerular filtration rate and increase whole-body glucose utilization. The results suggest the possibility that short-term C-peptide administration may exert a regulatory influence on renal function and stimulate glucose utilization in Type 1 diabetic patients. 相似文献
995.
Luc Mortelmans Estela Z. Cabrera Nicole Dorny John Thoeng Magda Wauters Frans van de Werf Johan VanHaecke Michel de Roo Hilaire de Geest 《The International Journal of Cardiac Imaging》1991,7(2):79-87
A miniaturized radionuclide cardiac probe incorporated in a semi-rigid plastic chest garment has made ambulatory left ventricular (LV) function evaluation possible, with gated nuclear data being stored on tape together with electrocardiographic data, for subsequent off-line processing.After red blood cell labelling with 555 MBq (15 mCi)99mTc and standard gated blood pool imaging in 45° LAO, we performed a continuous monitoring of LV function in 20 healthy male volunteers (age range: 22–25 years), in resting control conditions as well as during activities (standing, walking, climbing stairs) and after interventions (isosorbide dinitrate intake, Trendelenburg position, inflation of cuffs around the thighs).VEST-monitoring proved to be a reliable method that gave reproducible results: changes of ejection (EF) in basal conditions were lower than 5% in 95% of the patients. Changes in LV function caused by daily activities were easily demonstrated. While standing effected no significant EF changes, walking and climbing increased EF by 6.9% (p<0.05) and 21.2% (p<0.05) respectively.Changes in LV volumes caused by alterations in venous return were also demonstrated. Compared with baseline, Trendelenburg increased end-diastolic volume (EDV) by 2.9% while isosorbide dinitrate and inflation of cuffs decreased it by 5.7% and 2.2% respectively. 相似文献
996.
997.
998.
Sepsis,the Administration of IV Fluids,and Respiratory Failure: A Retrospective Analysis—SAIFR Study
999.
Mitral regurgitation (MR) is a common form of valvular heart disease that is associated with significant morbidity and mortality. Treatment decisions are completely dependent on accurate diagnosis of both mechanism and severity of MR, which can be challenging and is often done incorrectly. Transthoracic echocardiography is the most commonly used imaging test for MR; transesophageal echocardiography is often needed to better define morphology and MR severity, and is essential for guiding transcatheter therapies for MR. Multidetector computed tomography has become the standard to assess whether transcatheter valve replacement is an option because of its ability to assess valve sizing, access, and potential left ventricular outflow tract obstruction. Finally, cine cardiac magnetic resonance has been recommended by recent guidelines to quantify MR severity when the distinction between moderate and severe MR is indeterminate by echocardiography. This paper focuses on the main questions to be answered by imaging techniques and illustrates some common tips, tricks, and pitfalls in the assessment of MR. 相似文献
1000.
目的探讨参附注射液对慢性左心衰竭病人左心功能的影响.方法选择6例慢性左心衰竭病人,应用SPECT观察参附注射液注射前及注射后5 min、30min、60 min对左心功能各项指标的影响.结果参附注射液注射后较注射前左室射血分数(LVEF)下降(P<0.05或0.01),以30 min时下降最明显(P<0.01).结论参附注射液在短时间内能使慢性左心衰竭病人的左心功能下降. 相似文献